APA ציטוט

Reis, S. T., Pontes-Junior, J., Antunes, A. A., Dall’Oglio, M. F., Dip, N., Passerotti, C. C., . . . Leite, K. R. (2012). miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BioMed Central.

Citação norma Chicago

Reis, Sabrina Thalita, et al. MiR-21 May Acts As an Oncomir By Targeting RECK, a Matrix Metalloproteinase Regulator, in Prostate Cancer. BioMed Central, 2012.

ציטוט MLA

Reis, Sabrina Thalita, et al. MiR-21 May Acts As an Oncomir By Targeting RECK, a Matrix Metalloproteinase Regulator, in Prostate Cancer. BioMed Central, 2012.